Tahir Mahmood Biography and Net Worth

Tahir co-founded AMT, where he has overseen the company’s growth from concept to clinical trials in patients through multiple equity financing rounds. He was closely involved in the early development of the technology and also led the company’s partnering and corporate development activities.

With a career that has straddled science and business, Tahir previously led the US West Coast Life Sciences consulting practice at Booz Allen Hamilton and was Managing Director at Lake Sherwood Partners. As a consultant, he advised executives across the spectrum of life sciences, healthcare provider, private and public equity investment, and global health organizations.

Tahir is also co-founder and director of MiNDERA, a non-invasive skin genomics company with a technology platform he co-invented and developed as an investigator at The Scripps Research Institute. He served as Principal Business Analyst at Amgen, supporting business development, M&A and strategic venture fund transactions. Earlier, he was at Chienna (acquired by OctoPlus) and IsoTis S.A. (acquired by Integra Life Sciences). Tahir has authored numerous peer-reviewed publications and is inventor on issued and pending patents. He received BASc and MSc degrees from the University of Toronto. He holds a PhD in Chemical & Biomedical Engineering from a collaborative program between the University of Twente (The Netherlands) and Massachusetts Institute of Technology at the Harvard-MIT Division of Health Sciences and Technology and Boston Children’s Hospital.